Thyme Care Raises $125M, Launches New Oncology Parent Entity

Thyme Care completed a Series E funding round led by Morgan Health with participation from major healthcare investors including Humana, CVS Health Ventures, and a16z Bio + Health, while establishing a new oncology-focused parent entity. The funding demonstrates continued investment in digital oncology and patient support technology.